John Grieco
Lead Principal Investigator
John Grieco is a Research Professor in the Department of Biological Sciences. Prior to joining Notre Dame’s faculty, John earned a BS from Notre Dame, a MS from Texas A&M University, and a PhD from the Uniformed Services University of the Health Sciences in Bethesda, Maryland, where he later served as Associate Professor in the Division of Tropical Public Health. John currently manages a multidisciplinary research program with a focus on the biology, ecology, and transmission of vector-borne illnesses. He has a long history of working in the tropics on diseases such as malaria, Japanese Encephalitis, and Dengue, and he maintains active collaborations with researchers in several Asian and South American countries. John’s research focuses on the design of novel repellents, irritants, and toxicants for disease vector control and he has developed field and laboratory assays for identifying and optimizing behavior-modifying compounds for use in the control of mosquito, sand fly, and triatome vectors.
This project is made possible thanks to Unitaid funding and support. Unitaid is a global health agency engaged in finding innovative solutions to prevent, diagnose, and treat diseases more quickly, effectively, and for affordable prices, in low- and middle-income countries. Unitaid’s work includes funding initiatives to address major diseases such as HIV/AIDS, malaria, and tuberculosis, as well as HIV co-infections and co-morbidities such as cervical cancer and hepatitis C, and cross-cutting areas, such as fever management. Unitaid is now applying its expertise to address challenges in advancing new therapies and diagnostics for the COVID-19 pandemic, serving as a key member of the Access to COVID Tools Accelerator. Unitaid is hosted by the World Health Organization.